Eyepoint Pharmaceuticals Inc (EYPT)
Fair Value-9.0% Downside
Fair
Analyst230.9% Upside
Market Cap978.4 M
P/E-3.8x
Yield0.0%
HealthWeak
NASDAQ
Featured in
High-Beta Stocks
Small-Cap Stocks
Omeros Corporation (OMER)
Fair Value-40.4% Downside
Overvalued
Analyst160.9% Upside
Market Cap936.5 M
P/E10.9x
Yield0.0%
HealthGood
NASDAQ
Featured in
Overvalued Stocks
High-Beta Stocks
Small-Cap Stocks
SIGA Technologies Inc (SIGA)
Fair Value19.3% Upside
Undervalued
Market Cap232.4 M
P/E11.2x
Yield0.0%
HealthGood
NASDAQ
Featured in
High-Beta Stocks
Harrow Health Inc (HROW)
Fair Value22.2% Upside
Undervalued
Analyst72.0% Upside
Market Cap1.485 B
P/E-98.1x
Yield0.0%
HealthGood
NASDAQ
Featured in
Rapid Revenue Growth
High-Beta Stocks
High-Beta Momentum
High-Growth Small-Cap Stocks
Small-Cap Stocks
Aurora Cannabis Inc (ACB)
Fair Value37.9% Upside
Undervalued
Analyst114.0% Upside
Market Cap172.8 M
P/E-4.3x
Yield0.0%
HealthGood
NASDAQ
Featured in
High-Beta Stocks
Canopy Growth Corp (CGC)
Fair Value-0.7% Downside
Fair
Analyst33.2% Upside
Market Cap397.7 M
P/E-2.1x
Yield0.0%
HealthFair
NASDAQ
Featured in
High-Beta Stocks
Small-Cap Stocks
NRX Pharmaceuticals Inc (NRXP)
Fair Value7.5% Upside
Fair
Market Cap127.8 M
P/E-5.2x
Yield0.0%
HealthFair
NASDAQ
Featured in
High-Beta Stocks
High-Momentum Stocks
High-Beta Momentum
Cardiol Therapeutics Inc Class A (CRDL)
Fair Value-13.7% Downside
Fair
Analyst451.7% Upside
Market Cap158 M
P/E-6.0x
Yield0.0%
HealthFair
NASDAQ
Featured in
High-Beta Stocks
Technical Strength Leaders
Crinetics Pharmaceuticals Inc (CRNX)
Fair Value-8.2% Downside
Fair
Analyst1.8% Upside
Market Cap8.895 B
P/E-17.8x
Yield0.0%
HealthFair
NASDAQ
Featured in
Overvalued Stocks
High-Beta Stocks
High-Momentum Stocks
High-Beta Momentum
LENZ Therapeutics Inc (LENZ)
Fair Value45.6% Upside
Undervalued
Analyst507.2% Upside
Market Cap158.3 M
P/E-1.5x
Yield0.0%
HealthFair
NASDAQ
Featured in
High-Beta Stocks
Milestone Pharmaceuticals Inc (MIST)
Fair Value-6.7% Downside
Fair
Analyst453.1% Upside
Market Cap159.2 M
P/E-2.3x
Yield0.0%
HealthWeak
NASDAQ
Featured in
High-Beta Stocks
OrganiGram Holdings Inc (OGI)
Fair Value31.0% Upside
Undervalued
Market Cap137.6 M
P/E-7.4x
Yield0.0%
HealthGood
NASDAQ
Featured in
High-Beta Stocks
Phathom Pharmaceuticals Inc (PHAT)
Fair Value12.9% Upside
Fair
Analyst166.1% Upside
Market Cap671.2 M
P/E-6.6x
Yield0.0%
HealthFair
NASDAQ
Featured in
High-Beta Stocks
Small-Cap Stocks
Rani Therapeutics Holdings Inc (RANI)
Fair Value44.2% Upside
Undervalued
Analyst861.5% Upside
Market Cap111.8 M
P/E-3.0x
Yield0.0%
HealthFair
NASDAQ
Featured in
High-Beta Stocks
Regencell Bioscience Holdings Ltd (RGC)
Fair Value-47.8% Downside
Overvalued
Market Cap2.998 B
P/E-412.6x
Yield0.0%
HealthFair
NASDAQ
Featured in
Overvalued Stocks
High-Beta Stocks
Scilex Holding Co (SCLX)
Fair Value35.5% Upside
Undervalued
Market Cap45.504 M
P/E-0.1x
Yield0.0%
HealthWeak
NASDAQ
Featured in
High-Beta Stocks
Trevi Therapeutics Inc (TRVI)
Fair Value-43.9% Downside
Overvalued
Analyst40.4% Upside
Market Cap2.662 B
P/E-58.1x
Yield0.0%
HealthGood
NASDAQ
Featured in
Overvalued Stocks
High-Beta Stocks
High-Momentum Stocks
High-Beta Momentum
Verrica Pharmaceuticals Inc (VRCA)
Fair Value30.6% Upside
Undervalued
Analyst182.1% Upside
Market Cap92.937 M
P/E-5.3x
Yield0.0%
HealthFair
NASDAQ
Featured in
High-Beta Stocks
Xeris Pharmaceuticals Inc (XERS)
Fair Value-8.4% Downside
Fair
Analyst39.1% Upside
Market Cap1.484 B
P/E122.5x
Yield0.0%
HealthGreat
NASDAQ
Featured in
Rapid Revenue Growth
High-Beta Stocks
High-Beta Momentum
High-Growth Small-Cap Stocks
Small-Cap Stocks
Aardvark Therapeutics Inc (AARD)
Fair Value-3.3% Downside
Fair
Analyst92.8% Upside
Market Cap157.7 M
P/E-2.3x
Yield0.0%
HealthFair
NASDAQ
Featured in
High-Beta Stocks
Bioage Labs Inc (BIOA)
Fair Value37.1% Upside
Undervalued
Analyst263.2% Upside
Market Cap497.9 M
P/E-5.4x
Yield0.0%
HealthFair
NASDAQ
Featured in
Overvalued Stocks
High-Beta Stocks
Small-Cap Stocks
Biote Corp (BTMD)
Fair Value31.7% Upside
Undervalued
Analyst21.4% Upside
Market Cap80.705 M
P/E4.4x
Yield0.0%
HealthGreat
NASDAQ
Featured in
High-Beta Stocks
High-Beta Momentum
Cognition Therapeutics Inc (CGTX)
Fair Value-21.0% Downside
Overvalued
Analyst214.5% Upside
Market Cap88.254 M
P/E-4.8x
Yield0.0%
HealthFair
NASDAQ
Featured in
High-Beta Stocks
Journey Medical Corp (DERM)
Fair Value-21.5% Downside
Overvalued
Analyst110.9% Upside
Market Cap176.2 M
P/E-18.4x
Yield0.0%
HealthFair
NASDAQ
Featured in
High-Beta Stocks
High-Beta Momentum
MBX Biosciences Inc (MBX)
Fair Value-1.2% Downside
Fair
Analyst19.2% Upside
Market Cap3.365 B
P/E-37.1x
Yield0.0%
HealthGood
NASDAQ
Featured in
High-Beta Stocks
High-Momentum Stocks
High-Beta Momentum
Neonc Technologies Holdings Inc (NTHI)
Fair Value-8.9% Downside
Fair
Analyst357.1% Upside
Market Cap88.951 M
P/E-2.3x
Yield0.0%
HealthWeak
NASDAQ
Featured in
High-Beta Stocks
Neumora Therapeutics Inc (NMRA)
Fair Value32.8% Upside
Undervalued
Analyst287.8% Upside
Market Cap296.5 M
P/E-1.3x
Yield0.0%
HealthWeak
NASDAQ
Featured in
High-Beta Stocks
Rapport Therapeutics Inc (RAPP)
Fair Value-27.1% Downside
Overvalued
Analyst38.8% Upside
Market Cap2.018 B
P/E-19.0x
Yield0.0%
HealthGood
NASDAQ
Featured in
Overvalued Stocks
High-Beta Stocks
High-Beta Momentum
Small-Cap Stocks
